BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7400378)

  • 1. Effects of zomepirac on hemostasis in healthy adults and on platelet function in vitro.
    Mielke CH; Kahn SB; Muschek LD; Tighe JJ; Ng KT; Minn FL
    J Clin Pharmacol; 1980; 20(5-6 Pt 2):409-17. PubMed ID: 7400378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zomepirac and warfarin: a clinical study to determine if interaction exists.
    Minn FL; Zinny MA
    J Clin Pharmacol; 1980; 20(5-6 Pt 2):418-21. PubMed ID: 7400379
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the analgesic properties of zomepirac.
    Pruss TP; Gardocki JF; Taylor RJ; Muschek LD
    J Clin Pharmacol; 1980 Apr; 20(4):216-22. PubMed ID: 6247371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity.
    Hernandez MR; Tonda R; Pedreño J; Salas E; Arderiu G; Pino M; Serradell M; Escolar G
    J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):859-65. PubMed ID: 17122671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of halothane on platelet function.
    Dalsgaard-Nielsen J; Gormsen J
    Thromb Haemost; 1980 Dec; 44(3):143-5. PubMed ID: 7466741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of benoxaprofen and indomethacin on platelet function and biochemistry.
    Bang NU; Dwyer AM; Marks CA; Mattler LE; Heidenreich RO; Campbell SS; Ridolfo AS
    J Rheumatol Suppl; 1980; 6():27-35. PubMed ID: 6248641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers.
    Spowart K; Greer IA; McLaren M; Lloyd J; Bullingham RE; Forbes CD
    Thromb Haemost; 1988 Dec; 60(3):382-6. PubMed ID: 3266379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zomepirac--aspirin interactions in man.
    Desiraju RK; Nayak RK; Pritchard JF
    J Clin Pharmacol; 1984; 24(8-9):371-80. PubMed ID: 6480878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of effects of aspirin on platelet function in healthy volunteers: an analysis using the PFA-100.
    Konrad CJ; Schuepfer GK; Gerber H; Rukwied R; Schmelz M; Schley M
    J Clin Anesth; 2006 Feb; 18(1):12-7. PubMed ID: 16517326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589.
    Johnson FL; Boyer JL; Leese PT; Crean C; Krishnamoorthy R; Durham T; Fox AW; Kellerman DJ
    Platelets; 2007 Aug; 18(5):346-56. PubMed ID: 17654304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
    Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
    Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the pharmacokinetics and metabolism of zomepirac in man and animals.
    Muschek LD; Grindel JM
    J Clin Pharmacol; 1980 Apr; 20(4):223-9. PubMed ID: 6769977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zomepirac: an overview--concluding remarks of the symposium chairman.
    Beaver WT
    J Clin Pharmacol; 1980; 20(5-6 Pt 2):422-4. PubMed ID: 7400380
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.